90 related articles for article (PubMed ID: 29778234)
1. EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer.
Rattanapan Y; Korkiatsakul V; Kongruang A; Chareonsirisuthigul T; Rerkamnuaychoke B; Wongkularb A; Wilailak S
Cancer Genet; 2018 Aug; 224-225():37-40. PubMed ID: 29778234
[TBL] [Abstract][Full Text] [Related]
2. Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases.
Zhu X; Yang H; Lang J; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():103-108. PubMed ID: 31242460
[TBL] [Abstract][Full Text] [Related]
3. Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer.
Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Indian J Med Res; 2014 Nov; 140(5):616-23. PubMed ID: 25579142
[TBL] [Abstract][Full Text] [Related]
4. ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer.
Mase S; Shinjo K; Totani H; Katsushima K; Arakawa A; Takahashi S; Lai HC; Lin RI; Chan MWY; Sugiura-Ogasawara M; Kondo Y
Cancer Sci; 2019 Mar; 110(3):1105-1116. PubMed ID: 30633424
[TBL] [Abstract][Full Text] [Related]
5. Single CpG island methylation is not sufficient to maintain the silenced expression of CASPASE-8 apoptosis-related gene among women with epithelial ovarian cancer.
Braga Lda C; Silva LM; Ramos AP; Piedade JB; Vidigal PV; Traiman P; da Silva Filho AL
Biomed Pharmacother; 2014 Feb; 68(1):87-91. PubMed ID: 24412083
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
7. Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma.
Kim JY; Kim SH; Kim HS
Anticancer Res; 2019 May; 39(5):2361-2367. PubMed ID: 31092428
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
9. CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer.
Lin HW; Fu CF; Chang MC; Lu TP; Lin HP; Chiang YC; Chen CA; Cheng WF
Epigenomics; 2018 Nov; 10(11):1397-1413. PubMed ID: 30324802
[TBL] [Abstract][Full Text] [Related]
10. High Resolution Based Quantitative Determination of Methylation Status of CDH1 and VIM Gene in Epithelial Ovarian Cancer.
Thakur GK; Sharma T; Krishna Latha T; Banerjee BD; Shah HK; Guleria K
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2923-2928. PubMed ID: 31653136
[TBL] [Abstract][Full Text] [Related]
11. RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.
Amato E; Barbi S; Fassan M; Luchini C; Vicentini C; Brunelli M; Malleo G; Scarpa A; Malpeli G
BMC Cancer; 2016 Jan; 16():11. PubMed ID: 26754001
[TBL] [Abstract][Full Text] [Related]
12. Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.
Keita M; Wang ZQ; Pelletier JF; Bachvarova M; Plante M; Gregoire J; Renaud MC; Mes-Masson AM; Paquet ÉR; Bachvarov D
Gynecol Oncol; 2013 Feb; 128(2):356-63. PubMed ID: 23219462
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide de novo methylation in epithelial ovarian cancer.
Michaelson-Cohen R; Keshet I; Straussman R; Hecht M; Cedar H; Beller U
Int J Gynecol Cancer; 2011 Feb; 21(2):269-79. PubMed ID: 21270610
[TBL] [Abstract][Full Text] [Related]
14. Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas.
Choi YL; Kang SY; Shin YK; Choi JS; Kim SH; Lee SJ; Bae DS; Ahn G
Virchows Arch; 2006 Mar; 448(3):331-6. PubMed ID: 16315018
[TBL] [Abstract][Full Text] [Related]
15. Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice.
Li S; Li P; Liu W; Shang J; Qiu S; Li X; Liu W; Shi H; Zhou M; Liu H
Oxid Med Cell Longev; 2020; 2020():3158108. PubMed ID: 33456666
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis.
Ren F; Wang DB; Li T; Chen YH; Li Y
J Ovarian Res; 2014 Jul; 7():73. PubMed ID: 25298284
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
18. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of promoter hypermethylation of tumor suppressor gene BRCA1 in epithelial ovarian cancer.
Das J; Chandra L; Gandhi G; Amle DB; Patnayak RL; Khurana N; Saxena A
J Cancer Res Ther; 2022; 18(6):1578-1582. PubMed ID: 36412414
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
